by HAEMATO AG | Dec 15, 2020 | Ad-Hoc Announcement, Investor News
HEMATO AG acquires “M1 Aesthetics GmbH” from M1 Kliniken AG – Contribution of the company within the scope of a capital increase in kind of HAEMATO AG Berlin, 15.12.2020 – M1 Kliniken AG and HAEMATO AG today signed a contract for the... 
by HAEMATO AG | Nov 30, 2020 | Ad-Hoc Announcement, Investor News
HAEMATO AG: Expansion of the board of directors: Strengthening the strategic and operative implementation of the product business in the Haemato Group Schönefeld, 30.11.2020 – The supervisory board of HAEMATO AG has appointed Mr. Patrick Brenske to the board of... 
by Haemato AG | Jun 25, 2020 | Ad-Hoc Announcement, Allgemein, Investor News
HAEMATO AG: The Supervisory Board and the Executive Board have agreed that Mr Uwe Zimdars will leave the Executive Board of HAEMATO AG on June 30, 2020. Mr Zimdars is currently Executive Board Member of HAEMATO AG and Supervisory Board Member of M1 Kliniken AG. Due to... 
by Haemato AG | Jun 10, 2020 | Ad-Hoc Announcement
HAEMATO AG: Ad-hoc disclosure under Article 17 MAR HAEMATO AG: MPH Health Care AG brings its shares in HAEMATO AG to M1 Kliniken AG as part of a non-cash capital increase. Today MPH Health Care AG and M1 Kliniken AG informed us that MPH Health Care AG transfers all of... 
by Daniel Kracht | Apr 21, 2020 | Ad-Hoc Announcement, Investor News
Ad-hoc of HAEMATO AG: The Supervisory Board of HAEMATO AG (ISIN: DE0006190705) approved today’s proposal for the appropriation of profits by the Management Board in today’s balance sheet meeting. Accordingly, the Management will propose to the Annual... 
by HAEMATO AG | Jul 7, 2017 | Ad-Hoc Announcement
In today’s meeting, the Supervisory Board of HAEMATO AG (“HAEMATO” or the “Company”) accepted the wish of Dr. Christian Pahl to not extend his contract as Management Board Member beyond the current term ending 31 July 2017. The...
